InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 09/18/2020 12:15:10 PM

Friday, September 18, 2020 12:15:10 PM

Post# of 977
Just In: $TRIL Trillium Therapeutics Appoints Michael Kamarck, Ph.D., to Its Board of Directors

CAMBRIDGE, Mass., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the appointme...

Find out more TRIL - Trillium Therapeutics Appoints Michael Kamarck, Ph.D., to Its Board of Directors